GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, …
GARDASIL 9 is a vaccine indicated in females 9 through 45 years of age for the prevention of cervical, vulvar, vaginal, anal, oropharyngeal and other head and neck cancers caused by human papillomavirus (HPV) Types 16, 18, 31, 33, 45, 52, and 58; cervical, vulvar, vaginal, and anal precancerous or dysplastic lesions caused by HPV Types 6, 11, 16...
FDA Approves Merck's HPV Vaccine, GARDASIL®9, to Prevent …
Dec 11, 2014 · GARDASIL 9 includes the greatest number of HPV types in any available HPV vaccine Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA)
Merck to Present New Data From GARDASIL®9 Studies …
Nov 12, 2024 · RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that new clinical and real-world data for the company’s 9-valent Human Papillomavirus (HPV) vaccine, GARDASIL ® 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), evaluating the burden and incidence of …
Good Day for Gardasil as Merck Wins Safety Suit, Drops $1B for ...
2 days ago · Aside from Gardasil, Merck’s vaccine portfolio includes the 21-valent pneumococcal shot Capvaxive and the hepatitis A vaccine Vaqta. The company also produces shots for measles, mumps, rubella, ebola and other infectious diseases. In 2024, the Gardasil line was Merck’s second-best-selling product franchise, bringing in nearly $8.6 billion.
Gardasil - Wikipedia
Gardasil is an HPV vaccine for use in the prevention of certain strains of human papillomavirus (HPV). [10][7][8][9][11] It was developed by Merck & Co. [12] High-risk human papilloma virus (hr-HPV) genital infection is the most common sexually transmitted infection among women. [13] .
Merck triumphs in Gardasil safety litigation covering 200-plus suits
2 days ago · Late last month, a California jury trial over Gardasil side effects was put on hold until September, in a move Merck chalked up to its strong body of safety data on the vaccine.. One of the ...
FDA Approves Merck’s GARDASIL 9 for the Prevention of Certain …
Jun 12, 2020 · GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) Now Approved for the Prevention of HPV-Related Cervical, Vaginal, Vulvar, Anal, Oropharyngeal and Other Head and Neck Cancers.
Gardasil | FDA - U.S. Food and Drug Administration
Tradename: Gardasil Manufacturer: Merck & Co., Inc. Indications: Prevention of vulvar and vaginal cancer
Merck prevails in US safety litigation over Gardasil HPV vaccine
2 days ago · A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers caused by the human papillomavirus and one of ...
GARDASIL 9 | FDA - U.S. Food and Drug Administration
Mar 15, 2024 · Product approval information for Human Papillomavirus 9-valent Vaccine, Recombinant also known as Gardasil 9.
- Some results have been removed